Intracranial mesenchymal tumor, FET::CREB fusion-positive in the lateral ventricle.

Autor: Ozkizilkaya HI; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA., Johnson JM; Division of Diagnostic Imaging, Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, USA., O'Brien BJ; Division of Cancer Medicine, Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., McCutcheon IE; Division of Surgery, Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, USA., Prabhu SS; Division of Surgery, Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, USA., Ghia AJ; Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Fuller GN; Division of Diagnostic Imaging, Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, USA.; Division of Pathology and Lab Medicine, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA., Huse JT; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.; Division of Pathology and Lab Medicine, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA., Ballester LY; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.; Division of Pathology and Lab Medicine, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Jazyk: angličtina
Zdroj: Neuro-oncology advances [Neurooncol Adv] 2023 Mar 21; Vol. 5 (1), pp. vdad026. Date of Electronic Publication: 2023 Mar 21 (Print Publication: 2023).
DOI: 10.1093/noajnl/vdad026
Abstrakt: Competing Interests: The authors have no relevant financial or non-financial interests to disclose.
Databáze: MEDLINE